Skip to main content

Curaleaf Stock Forecast, Price & News

+0.66 (+4.81 %)
(As of 05/14/2021 08:27 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume547,257 shs
Average Volume1.30 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CURLF News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

Curaleaf logo

About Curaleaf

Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers oil-based formulations, such as vaporizing, cartridges, tinctures, and capsules; and ground-flower. The company also provides hemp-based CBD products. As of March 9, 2021, it operated 101 dispensaries, 23 cultivation sites, and 30 processing sites in 23 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.


See More Headlines

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

1.62 out of 5 stars

Medical Sector

399th out of 2,032 stocks

Drug Manufacturers - Specialty & Generic Industry

4th out of 61 stocks

Analyst Opinion: 4.4Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Curaleaf (OTCMKTS:CURLF) Frequently Asked Questions

Is Curaleaf a buy right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last twelve months. There are currently 1 sell rating and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Curaleaf stock.
View analyst ratings for Curaleaf
or view top-rated stocks.

What stocks does MarketBeat like better than Curaleaf?

Wall Street analysts have given Curaleaf a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Curaleaf wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were Curaleaf's earnings last quarter?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) announced its quarterly earnings results on Monday, March, 8th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.03.
View Curaleaf's earnings history

How has Curaleaf's stock price been impacted by COVID-19 (Coronavirus)?

Curaleaf's stock was trading at $4.42 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CURLF shares have increased by 225.8% and is now trading at $14.40.
View which stocks have been most impacted by COVID-19

What price target have analysts set for CURLF?

9 Wall Street analysts have issued 1 year target prices for Curaleaf's stock. Their forecasts range from $16.00 to $32.25. On average, they anticipate Curaleaf's share price to reach $22.50 in the next year. This suggests a possible upside of 56.3% from the stock's current price.
View analysts' price targets for Curaleaf
or view top-rated stocks among Wall Street analysts.

Who are Curaleaf's key executives?

Curaleaf's management team includes the following people:
  • Mr. Boris Alexis Jordan, Exec. Chairman (Age 55, Pay $750k)
  • Mr. Joseph F. Lusardi, Exec. Vice-Chairman (Age 46, Pay $1.01M)
  • Mr. Neil P. Davidson CPA, COO & Treasurer (Age 49, Pay $538.5k)
  • Mr. Joseph Daniel Bayern, Chief Exec. Officer (Age 58)
  • Mr. Christine Taylor, Sr. VP of Fin. & Accounting
  • Mr. Carlos Madrazo, Sr. VP of Investor Relations & Capital Markets
  • Mr. Peter Clateman, Chief Legal Officer (Age 53)
  • Mr. James S. Shorris, Chief Compliance Officer (Age 59)
  • Ms. Tracy Brady, VP of Corp. Communications
  • Ms. Carolyn Fedigan, Sr. VP of HR (Age 57)

Who are some of Curaleaf's key competitors?

What is Curaleaf's stock symbol?

Curaleaf trades on the OTCMKTS under the ticker symbol "CURLF."

How do I buy shares of Curaleaf?

Shares of CURLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Curaleaf's stock price today?

One share of CURLF stock can currently be purchased for approximately $14.40.

What is Curaleaf's official website?

The official website for Curaleaf is

How can I contact Curaleaf?

The company can be reached via phone at 781-451-0150.

This page was last updated on 5/17/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.